BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35978050)

  • 1. A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver.
    Akita M; Maeda E; Ishida R; Morikawa T; Nishimura T; Abe K; Kozuki A; Tanaka T; Kaneda K
    Langenbecks Arch Surg; 2022 Nov; 407(7):3141-3146. PubMed ID: 35978050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases.
    Yu P; Hu C; Wang Y; Bao Z; Zhang R; Cao M; Zhang Y; Cheng X; Xu Z
    BMC Surg; 2022 Nov; 22(1):401. PubMed ID: 36404297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Preoperative Chemotherapy for Advanced Gastric Cancer, Laparoscopic Total Gastrectomy, Pancreaticoduodenectomy, and Para-Aortic Lymph Node Dissection].
    Fukuda K; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1438-1440. PubMed ID: 38303300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three Cases of No. 16 Lymph Node Metastasis-Positive Gastric Cancer Successfully Treated with Chemotherapy and Para-Aortic Lymph Node Dissection].
    Tamaki S; Taniguchi K; Katsuragawa H; Hataji K; Okamoto F; Hayashi T; Ishii M; Tateno Y; Kanada Y; Yagi M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2048-2051. PubMed ID: 35045489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer.
    Endo S; Ikenaga M; Yamada T; Tamura S; Sasaki YO
    Anticancer Res; 2020 Apr; 40(4):2351-2357. PubMed ID: 32234937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
    Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable Outcomes of Neoadjuvant Chemotherapy and Limited Para-Aortic Lymph Node Dissection for Advanced Gastric Cancer with Para-aortic Lymph Node Metastasis.
    Ri M; Ohashi M; Eto K; Ishizuka N; Atsumi S; Makuuchi R; Ida S; Kumagai K; Sano T; Nunobe S
    World J Surg; 2021 Sep; 45(9):2849-2859. PubMed ID: 34031711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
    Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
    World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial.
    Lu S; Chen YG; Liu XW; Yang ZY; Shi M; Yuan H; Liu WT; Ni ZT; Yao XX; Hua ZC; Feng RH; He CY; Zheng YN; Wang ZQ; Sah BK; Chen MM; Zhu ZL; Li C; Zhang J; Yan M; Xia JZ; Zhu ZG; Yan C
    Future Oncol; 2022 Dec; 18(39):4239-4349. PubMed ID: 36651765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Wada T; Yoshikawa T; Sekine S; Kamiya A; Hayashi T; Otsuki S; Yamagata Y; Katai H
    Eur J Surg Oncol; 2022 Feb; 48(2):333-338. PubMed ID: 34284903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
    Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
    Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.
    Yamao T; Ohta K; Ohyama S; Ishihara S; Chin K; Maruyama M; Takahashi T; Nakajima T
    Jpn J Clin Oncol; 2004 May; 34(5):255-61. PubMed ID: 15231860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic curative para-aortic lymph node dissection via INfra-mesocolon for gastric cancer: Robotic CAVING approach.
    Ojima T; Hayata K; Kitadani J; Yamaue H
    Surg Oncol; 2021 Dec; 39():101658. PubMed ID: 34624690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients who received paraaortic lymph node dissection for locally advanced gastric cancer with extensive lymph node metastasis.
    Hikage M; Fujiya K; Kamiya S; Tanizawa Y; Bando E; Notsu A; Terashima M
    Langenbecks Arch Surg; 2022 May; 407(3):1027-1037. PubMed ID: 35022832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case treated successfully with low-dose CDDP and 5-FU for the treatment of liver and para-aortic lymph node metastases and second metastasis to anterior mediastinum lymph nodes from gastric cancer after gastrectomy].
    Misawa K; Sano H; Sato T; Naka M; Suzuki S; Okawa Y; Yoneyama S; Nakanishi Y; Takada A
    Gan To Kagaku Ryoho; 2002 May; 29(5):757-60. PubMed ID: 12040680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of para-aortic lymph node dissection in patients with advanced and recurrent gastric cancer.
    Inada T; Ogata Y; Andoh J; Ozawa I; Matsui J; Hishinuma S; Shimizu H; Kotake K; Koyama Y
    Anticancer Res; 1994; 14(2B):677-82. PubMed ID: 8010726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.
    Mengardo V; Bencivenga M; Weindelmayer J; Pavarana M; Giacopuzzi S; de Manzoni G
    Updates Surg; 2018 Jun; 70(2):207-211. PubMed ID: 29846892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.